Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 23 articles: HTML format

Single Articles

September 2021
1. HENROT P, Beaufils F, Thumerel M, Eyraud E, et al
   Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
   Eur Respir J. 2021 Sep 24. pii: 13993003.01221-2021.
   PubMed    
   
   
   July 2021
2. LI G, Zhang X, Liu Y, Zhang J, et al
   Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.
   Eur Respir J. 2021 Jul 29. pii: 13993003.01399-2021.
   PubMed     Abstract available
   
   
   June 2021
3. CHERNBUMROONG S, Johnson J, Gupta N, Miller S, et al
   Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
   Eur Respir J. 2021;57.
   PubMed     Abstract available
   
   
   April 2021
4. MALDONADO F, Varghese C, Rajagopalan S, Duan F, et al
   Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.
   Eur Respir J. 2021;57.
   PubMed     Abstract available
   
   
   March 2021
5. HASANI AM, Matthew B, Goljamali M, Chen YC, et al
   Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study.
   Eur Respir J. 2021;57.
   PubMed    
   
   
   
6. FERNANDES S, Williams G, Williams E, Ehrlich K, et al
   Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.
   Eur Respir J. 2021;57.
   PubMed     Abstract available
   
   
   February 2021
7. SCHREUDER A, Jacobs C, Lessmann N, Broeders MJ, et al
   Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening.
   Eur Respir J. 2021 Feb 11. pii: 13993003.03386-2020.
   PubMed     Abstract available
   
   
   January 2021
8. BETSER L, Glorion M, Mordant P, Caramella C, et al
   Cannabis use and lung cancer: time to stop overlooking the problem?
   Eur Respir J. 2021 Jan 28. pii: 13993003.04132-2020.
   PubMed    
   
   
   
9. BALDWIN DR, Callister ME, Crosbie PA, O'Dowd EL, et al
   Biomarkers in lung cancer screening: the importance of study design.
   Eur Respir J. 2021;57.
   PubMed    
   
   
   December 2020
10. KRISTOF AS
    Novel rare genetic variants in idiopathic pulmonary fibrosis.
    Eur Respir J. 2020;56.
    PubMed    
    
    
    November 2020
11. INFANTE MV, Cardillo G
    Lung cancer screening in never-smokers: facts and remaining issues.
    Eur Respir J. 2020;56.
    PubMed    
    
    
    
12. VALLIERES E
    The optimal treatment of stage I nonsmall cell lung cancer in the era of SABR and modern day lung resections.
    Eur Respir J. 2020;56.
    PubMed    
    
    
    October 2020
13. GAGA M, Chorostowska-Wynimko J, Horvath I, Tammemagi MC, et al
    Validation of Lung EpiCheck(R), a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals.
    Eur Respir J. 2020 Oct 29. pii: 13993003.02682-2020.
    PubMed     Abstract available
    
    
    
14. BOUSEMA JE, Aarts MJ, Dijkgraaf MGW, Annema JT, et al
    Trends in mediastinal nodal staging and its impact on unforeseen N2 and survival in lung cancer.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01549-2020.
    PubMed     Abstract available
    
    
    August 2020
15. LEGENDRE M, Butt A, Borie R, Debray MP, et al
    Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.
    Eur Respir J. 2020 Aug 27. pii: 13993003.02806-2020.
    PubMed     Abstract available
    
    
    
16. GARNER JL, Shah PL
    Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic.
    Eur Respir J. 2020;56.
    PubMed    
    
    
    July 2020
17. SULLIVAN FM, Mair FS, Anderson W, Armory P, et al
    Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
    Eur Respir J. 2020 Jul 30. pii: 13993003.00670-2020.
    PubMed     Abstract available
    
    
    
18. FRANKS KN, McParland L, Webster J, Baldwin DR, et al
    SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resect
    Eur Respir J. 2020 Jul 2. pii: 13993003.00118-2020.
    PubMed     Abstract available
    
    
    June 2020
19. KIM YW, Kang HR, Kwon BS, Lim SY, et al
    Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers.
    Eur Respir J. 2020 Jun 1. pii: 13993003.00177-2020.
    PubMed     Abstract available
    
    
    May 2020
20. LAVOLE A, Greillier L, Mazieres J, Monnet I, et al
    First-Line Carboplatin Plus Pemetrexed with Pemetrexed Maintenance in HIV+ Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: The Phase II IFCT-1001 CHIVA Trial.
    Eur Respir J. 2020 May 22. pii: 13993003.02066-2019.
    PubMed     Abstract available
    
    
    
21. RASKIN J, Lebeer M, De Bondt C, Wener R, et al
    Cancer in the time of COVID-19: expert opinion on how to adapt current practice.
    Eur Respir J. 2020;55.
    PubMed    
    
    
    March 2020
22. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    
    
    
    
23. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: